Meeder Asset Management Inc. raised its position in LivaNova PLC (NASDAQ:LIVN) by 9.7% in the fourth quarter, Holdings Channel reports. The institutional investor owned 15,675 shares of the company’s stock after purchasing an additional 1,381 shares during the period. Meeder Asset Management Inc.’s holdings in LivaNova were worth $1,252,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. PNC Financial Services Group Inc. increased its holdings in shares of LivaNova by 9.8% in the second quarter. PNC Financial Services Group Inc. now owns 1,707 shares of the company’s stock valued at $105,000 after purchasing an additional 153 shares during the period. Cerebellum GP LLC acquired a new position in shares of LivaNova in the fourth quarter valued at approximately $128,000. Pillar Pacific Capital Management LLC acquired a new position in shares of LivaNova in the fourth quarter valued at approximately $208,000. Shelton Capital Management acquired a new position in shares of LivaNova in the third quarter valued at approximately $209,000. Finally, Crossmark Global Holdings Inc. acquired a new position in shares of LivaNova in the third quarter valued at approximately $263,000. Institutional investors own 88.50% of the company’s stock.

In related news, Director Hugh M. Morrison sold 1,830 shares of the company’s stock in a transaction on Wednesday, November 29th. The stock was sold at an average price of $88.00, for a total transaction of $161,040.00. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Alfred J. Novak sold 2,000 shares of the company’s stock in a transaction on Wednesday, November 22nd. The stock was sold at an average price of $85.77, for a total value of $171,540.00. The disclosure for this sale can be found here. Insiders have sold 6,830 shares of company stock worth $576,920 in the last ninety days. 0.28% of the stock is currently owned by corporate insiders.

A number of research firms have recently issued reports on LIVN. Zacks Investment Research raised LivaNova from a “hold” rating to a “buy” rating and set a $89.00 target price on the stock in a report on Thursday, November 9th. BTIG Research reissued a “hold” rating on shares of LivaNova in a report on Tuesday, November 7th. Piper Jaffray Companies reissued a “buy” rating and issued a $85.00 target price on shares of LivaNova in a report on Friday, November 3rd. BidaskClub raised LivaNova from a “hold” rating to a “buy” rating in a report on Friday, January 26th. Finally, Canaccord Genuity reissued a “hold” rating and issued a $76.00 target price on shares of LivaNova in a report on Tuesday, December 5th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $79.71.

LivaNova PLC (LIVN) opened at $83.31 on Thursday. LivaNova PLC has a twelve month low of $45.67 and a twelve month high of $88.56. The firm has a market capitalization of $3,989.99, a price-to-earnings ratio of 23.85, a P/E/G ratio of 2.46 and a beta of 0.83. The company has a current ratio of 2.03, a quick ratio of 1.42 and a debt-to-equity ratio of 0.04.

WARNING: “Meeder Asset Management Inc. Raises Holdings in LivaNova PLC (LIVN)” was first reported by Watch List News and is the property of of Watch List News. If you are accessing this piece on another site, it was stolen and reposted in violation of U.S. and international copyright and trademark law. The original version of this piece can be read at https://www.watchlistnews.com/meeder-asset-management-inc-raises-holdings-in-livanova-plc-livn/1852727.html.

LivaNova Profile

LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.

Want to see what other hedge funds are holding LIVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LivaNova PLC (NASDAQ:LIVN).

Institutional Ownership by Quarter for LivaNova (NASDAQ:LIVN)

Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.